Life-science briefing: Friday, April 11, 2008
TODAY’S HEADLINES:
Stent maker IDev Tech raises $25M (VentureWire)
Xytis gets $15M for brain-injury drugs (VentureWire)
Diagnostic maker Iris Biotech plans to go public, launch breast-cancer test (Edgar)
RiverVest Venture Partners raises $75M life-science fund (release)
Concentric Medical names Maria Sainz CEO (release)
[Note: I’m a little sad to announce that this will be my last life-science briefing at VentureBeat, although with luck, it won’t be the end of my time here. Starting Monday, I’ll be blogging regularly on the drug industry and… Continue Reading
Security company Imperva raises $20M
Imperva, a company that provides application data security, has raised $20 million in a fourth round of financing. The company’s total funding is now $54 million.
We covered the Foster City, Calif.-company back in 2006, when chief executive Shlomo Kramer (who co-founded the successful security firewall company Check Point Software Technologies) told us Imperva stands out because primarily targets database security.
The round was led by Meritech Capital Partners. Previous investors Accel Partners, Greylock Ventures, US Venture… Continue Reading